Leitrim, Ireland

Cathal Duignan

This inventor holds 1 USPTO granted patent. Top assignee: Circassia Ab. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cathal Duignan. Retrieved from https://idiyas.com/inventor/cathal-duignan-1bfbgm3l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cathal Duignan: Innovator in Medical Technology

Introduction

Cathal Duignan is a notable inventor based in Leitrim, Ireland. He has made significant contributions to the field of medical technology, showcasing his innovative spirit through his patents.

Latest Patents

Cathal holds a patent for a medical apparatus, which reflects his commitment to advancing healthcare solutions. This patent is a testament to his ingenuity and dedication to improving medical devices.

Career Highlights

Throughout his career, Cathal has worked with Circassia Ab, a company focused on developing innovative treatments for respiratory diseases. His role at Circassia Ab has allowed him to apply his expertise in medical technology and contribute to meaningful advancements in the field.

Collaborations

Cathal has collaborated with talented individuals such as James Jamieson and Helen Westbrook. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Cathal Duignan is a distinguished inventor whose work in medical technology has the potential to impact many lives. His dedication to innovation and collaboration highlights the importance of teamwork in achieving groundbreaking advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…